Eksperimental'naia i klinicheskaia farmakologiia 2013-01-01

[Estimating ability of dihydroquercetin to inhibit oxidation of fibrinogen by ozone].

V S Rogovskiĭ, M A Rozenfel'd, S D Razumovskiĭ, A I Matiushin, N L Shimanovskiĭ, B V Leonova, M L Konstantinova

Index: Eksp. Klin. Farmakol. 76(3) , 23-6, (2013)

Full Text: HTML

Abstract

The ability of dihydroquercetin to inhibit the oxidation of fibrinogen has been evaluated. It is established that dihydroquercetin inhibits oxidation of fibrinogen by ozone, thus preventing oxidative modification of fibrinogen and preserving its functional activity.

Related Compounds

Related Articles:

Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates?

2013-11-01

[Anesth. Analg. 117(5) , 1063-71, (2013)]

A re-assessment of long distance growth and connectivity of neural stem cells after severe spinal cord injury.

2014-07-01

[Exp. Neurol. 257 , 186-204, (2014)]

Novel thrombolytic protease from edible and medicinal plant Aster yomena (Kitam.) Honda with anticoagulant activity: purification and partial characterization.

2014-10-01

[J. Biosci. Bioeng. 118(4) , 372-7, (2014)]

The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.

2015-01-01

[Immunology 144(1) , 91-106, (2015)]

Effects of fibrinogen concentration on fibrin glue and bone powder scaffolds in bone regeneration.

2014-10-01

[J. Biosci. Bioeng. 118(4) , 469-75, (2014)]

More Articles...